New

VOM V

In Stock

$ 32

VOM V is a filler based on hyaluronic acid for the correction of fine lines. Given product is the first one from the cognominal series and is perfectly suitable for the management of first hallmarks of skin aging. The base of the filler is cross-linked polymeric hyaluronic acid that effectively binds the water. Since the product is injected to the intra-dermal layer, it is possible to reach pointwise correction of the most fine lines in the eye, lips and neck areas. The solution represents the unique multiphase formula that is stable and has optimal viscosity that prevents migration of the product form the injection zone. In addition, the unique manufacturing technology increases the stability of hyaluronic acid in the composition. Such modification additionally enhances the consistency of the product and provides more long-lasting effect from the procedures.

 

Strengths of VOM V:

the product is injected to the intra dermal layer and acts delicately and pointwise

the composition contains lidocaine and injections are undergoing almost painless

suitable for young patients which are needed the light correction of first age-related skin changes

the filler not only effectively fills the volumes on face but also moisturizes skin

VOM V is injected for:

elimination of fine lines

flattering of marionette-lines and “crow’s feet” wrinkles

correction of fine lines in the neck area

elimination of light wrinkles in the lips area

Product composition: Hyaluronic Acid 20 mg/ml, 0.3% Lidocaine Hydrochloride

VOM V

2 pre-filled syringes × 1.0 ml

Needle size: 27 G 1/2’, 30 G 1/2’

Reviews for VOM V

Add a review

Write a message

Please rate on a scale of 5

Related Products

Liporase
Liporase
Injection
$43
Aesthefill
Aesthefill
Fillers
$223
Rejeunesse Deep
Rejeunesse Deep
Fillers
$35
Rejeunesse Shape
popular
$35
Rejeunesse Fine
Rejeunesse Fine
Fillers
$35
Celosome Mid
Celosome Mid
Fillers
$37
Celosome Soft
Celosome Soft
Fillers
$37
Celosome Strong
Celosome Strong
Fillers
$37

20% Discount!
Subscribe to our newsletter